Palmitoylethanolamide (PEA), a naturally occurring fatty acid, is increasingly catching the attention of the dietary supplement sector owing to its potential health advantages. Research has ...

It combines the psychedelic compound Ibogaine with Palmitoylethanolamide, which is a member of the N-Acylethanolamines family. It aims to improve the safety and efficacy of Ibogaine-based treatments.

Under the collaboration, SciSparc and Clearmind are researching combination therapies that integrate psychedelic molecules with the N-acylethanolamines family, including Palmitoylethanolamide.